Sealonix is engaged in the development and commercialization of hemostatic sealants aimed at enhancing surgical procedures. The company is advancing its proprietary biomaterials to create a sealant patch that facilitates rapid hemostasis during abdominopelvic and orthopedic operations. This innovative PramStat patch is designed to bioabsorb within one week of implantation, providing an efficient solution for the healthcare industry in managing bleeding during surgeries.
Rejoni, Inc. is a medical device company specializing in gynecological surgical procedures, focusing on the development and commercialization of products that reduce the risk of scar formation after intrauterine interventions. Founded in 2020 and based in Bedford, Massachusetts, Rejoni aims to enhance the outcomes of both minimally invasive and traditional gynecological surgeries. By utilizing biomaterials, the company seeks to address both acute and chronic risks associated with these procedures, ultimately providing women with technologies that support their overall health and well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.